Cancer Genetics Inc
CGIX
Delayed Nasdaq - 08/18 10:00:00 pm
3.3USD
0%
Upcoming events
08/22/17 | 14:30
Business Update Call
Past Events
08/14/17 | 11:00pmInterim 2017 Earnings Call
08/14/17Interim 2017 Earnings Release
06/19/17BIO International Convention
06/07/17Annual General Meeting
Annual results
Annual results20162017 (e)
Sales
Million $
Released
Forecast
Spread
27,0
26,9
0,55%

31,2
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-14,3
-14,5
1,0%


Operating profit (EBIT)
Million $
Released
Forecast
Spread
-16,7
-17,0
1,3%

-9,86
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-15,8
-17,1
7,3%

-18,0
Net income
Million $
Released
Forecast
Spread
-15,8
-17,1
7,3%

-17,0
EPS
 $
Released
Forecast
Spread
-1,00
-1,10
9,1%

-0,87
Announcement Date03/23/2017
Quarterly / Semiannualy publications
Quarterly resultsQ2
2017
Q3
2017 (e)
Sales
Million $
Released
Forecast
Spread
6,60
7,97
-17%

8,00
Operating income (EBITDA)
 
Released
Forecast
Spread




Operating profit (EBIT)
Million $
Released
Forecast
Spread
-3,11
-2,50
-24%

-2,35
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-2,77
-2,94
5,9%

-2,55
Net income
Million $
Released
Forecast
Spread
-2,77
-2,94
5,9%

-2,55
EPS
 $
Released
Forecast
Spread
-0,16
-0,15
-6,7%

-0,12
Announcement Date08/14/2017
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise